UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000007738
Receipt No. R000009116
Official scientific title of the study Multi-center cohort study on the postoperative outcomes of Discovery total elbow arthroplasty
Date of disclosure of the study information 2012/04/13
Last modified on 2018/02/06 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Multi-center cohort study on the postoperative outcomes of Discovery total elbow arthroplasty
Title of the study (Brief title) Cohort study of Discovery total elbow arthroplasty
Region
Japan

Condition
Condition elbow arthropathy
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To observe the efficacy and safety of total elbow arthroplasty using Discovery total elbow by multi-center cohort study in Japan
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes MEPS, radiological loosening, ratios of revision after 3 years
Key secondary outcomes ratios of operative complications, disease activity for rheumatoid arthritis patients (DAS28, SDAI)

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with elbow arthropathy with
1) radiological joint destruction (Larsen grade 3 or above) and ADL disability in RA patients, or
2) radiological joint destruction (K-L grade 3 or above) and ADL disability in OA patients
Key exclusion criteria 1) severe neurological symptoms in the upper limb
2) cognitive conditions
3) fracture of the elbow
4) conditions more suitable for other elbow arhthrplasties
5) revision arthroplasty
Target sample size 50

Research contact person
Name of lead principal investigator Hiromu Ito
Organization Kyoto University Graduate School of Medicine
Division name Department of Orthopaedic Surgery
Address 54 Kawahara-cho, Shogoin,Sakyo, Kyoto 606-8507, Japan
TEL 075-751-3877
Email hiromu@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Hiromu Ito
Organization Kyoto University Hospital
Division name Department of Orthopedic Surgery
Address 54 Kawahara-cho, Shogoin,Sakyo, Kyoto 606-8507, Japan
TEL 075-751-3877
Homepage URL
Email hiromu@kuhp.kyoto-u.ac.jp

Sponsor
Institute Kyoto University Hospital, Department of Orthopaedic Surgery
Institute
Department

Funding Source
Organization BMS, Ono
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 04 Month 13 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2012 Year 04 Month 12 Day
Anticipated trial start date
2012 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information 1) preoperative conditions including MEPS, ROM, ADL disabilities, disease activity and radiological evaluations
2) duration of the operation, blood loss, fixation period
3) periopertive complications
4) postoperative conditions including MEPS, ROM, ADL disabilities, disease activity and radiological evaluations

Management information
Registered date
2012 Year 04 Month 13 Day
Last modified on
2018 Year 02 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009116